{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:57Z","timestamp":1786997937191,"version":"build-2736575974"},"reference-count":72,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T00:00:00Z","timestamp":1485388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vaccine.2017.01.042","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T12:16:33Z","timestamp":1510661793000},"page":"6546-6554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"PA","title":["Fetal growth restriction: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data"],"prefix":"10.1016","volume":"35","author":[{"given":"Sarah Rae","family":"Easter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda O.","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nansi","family":"Boghossian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Oteng-Ntim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasi","family":"Patwardhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margo S.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gravett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"McKelvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitali","family":"Pool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Kochhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"McElrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"346","key":"10.1016\/j.vaccine.2017.01.042_b0005","doi-asserted-by":"crossref","first-page":"f108","DOI":"10.1136\/bmj.f108","article-title":"Maternal and fetal risk factors for stillbirth: population based study","volume":"24","author":"Gardosi","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.vaccine.2017.01.042_b0010","doi-asserted-by":"crossref","first-page":"318e1","DOI":"10.1016\/j.ajog.2012.06.039","article-title":"The risk of intrauterine fetal death in the small-for-gestational-age fetus","volume":"207","author":"Pilliod","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.01.042_b0015","doi-asserted-by":"crossref","first-page":"130e1","DOI":"10.1016\/j.ajog.2012.11.014","article-title":"Perinatal complications and long-term neurodevelopmental outcome of infants with intrauterine growth restriction","volume":"208","author":"von Beckerath","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.01.042_b0020","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/uog.13190","article-title":"Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)","volume":"42","author":"Lees","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9983","key":"10.1016\/j.vaccine.2017.01.042_b0025","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(14)62049-3","article-title":"2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial","volume":"385","author":"Lees","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2017.01.042_b0030","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.puhe.2014.06.022","article-title":"Preventing stillbirths through improved antenatal recognition of pregnancies at risk due to growth restriction","volume":"128","author":"Gardosi","year":"2014","journal-title":"Public Health"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2017.01.042_b0035","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-2458-11-S3-S1","article-title":"Screening and triage of intrauterine growth restriction (IUGR) in general population and high risk pregnancies: a systematic review with a focus on reduction of IUGR related stillbirths","volume":"11","author":"Imdad","year":"2011","journal-title":"BMC Public Health"},{"issue":"10008","key":"10.1016\/j.vaccine.2017.01.042_b0040","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0140-6736(15)00131-2","article-title":"Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study","volume":"386","author":"Sovio","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2017.01.042_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.11.025","article-title":"Intrauterine growth restriction: comparison of American College of Obstetricians and Gynecologists practice bulletin with other national guidelines","volume":"200","author":"Chauhan","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.01.042_b0050","first-page":"307","article-title":"Guidelines on fetal growth restriction: a comparison of recent national publications","volume":"32","author":"Unterscheider","year":"2015","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.vaccine.2017.01.042_b0055","doi-asserted-by":"crossref","unstructured":"ACOG Practice bulletin no. 134: fetal growth restriction. Obstet Gynecol. 2013 May;121(5):1122-33.","DOI":"10.1097\/01.AOG.0000429658.85846.f9"},{"key":"10.1016\/j.vaccine.2017.01.042_b0060","unstructured":"Green-top guidelines. London, UK: Royal College of Obstetricians and Gynaecologists; 2013. Available on the world wide web: https:\/\/www.rcog.org.uk\/globalassets\/documents\/guidelines\/gtg_31.pdf [last accessed January 16, 2016]."},{"issue":"1","key":"10.1016\/j.vaccine.2017.01.042_b0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1701-2163(16)35129-5","article-title":"Screening, diagnosis, and management of intrauterine growth restriction","volume":"34","author":"Lausman","year":"2012","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.vaccine.2017.01.042_b0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2015.06.021","article-title":"Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians","volume":"193","author":"Vayssiere","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"10","key":"10.1016\/j.vaccine.2017.01.042_b0075","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.earlhumdev.2009.09.004","article-title":"Distinguishing pathological from constitutional small for gestational age births in population-based studies","volume":"85","author":"Ananth","year":"2009","journal-title":"Early Hum Dev"},{"issue":"2 Pt 1","key":"10.1016\/j.vaccine.2017.01.042_b0080","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/AOG.0b013e31829ca9a7","article-title":"The role of growth trajectories in classifying fetal growth restriction","volume":"122","author":"Barker","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.01.042_b0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0002-9378(85)90298-4","article-title":"Estimation of fetal weight with the use of head, body, and femur measurements\u2014a prospective study","volume":"151","author":"Hadlock","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.01.042_b0090","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1471-0528.2012.03451.x","article-title":"Systematic review of methodology used in ultrasound studies aimed at creating charts of fetal size","volume":"119","author":"Ioannou","year":"2012","journal-title":"BJOG"},{"issue":"25","key":"10.1016\/j.vaccine.2017.01.042_b0095","first-page":"e1","article-title":"A customized standard to assess fetal growth in a US population","volume":"201","author":"Gardosi","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.01.042_b0100","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1471-0528.2009.02245.x","article-title":"The value of customized centiles in assessing perinatal mortality risk associated with parity and maternal size","volume":"116","author":"Gardosi","year":"2009","journal-title":"BJOG"},{"issue":"9780","key":"10.1016\/j.vaccine.2017.01.042_b0105","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(11)60364-4","article-title":"A global reference for fetal-weight and birthweight percentiles","volume":"377","author":"Mikolajczyk","year":"2011","journal-title":"Lancet"},{"issue":"9946","key":"10.1016\/j.vaccine.2017.01.042_b0110","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(14)61490-2","article-title":"International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project","volume":"384","author":"Papageorghiou","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2017.01.042_b0115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ajog.2012.01.022","article-title":"Doppler assessment of the fetus with intrauterine growth restriction","volume":"206","author":"Berkley","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.01.042_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2013.02.007","article-title":"Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study","volume":"208","author":"Unterscheider","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.vaccine.2017.01.042_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.06.047","article-title":"Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System","volume":"205","author":"Moro","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"18","key":"10.1016\/j.vaccine.2017.01.042_b0130","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/jama.2014.14825","article-title":"Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes","volume":"312","author":"Kharbanda","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2017.01.042_b0135","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/AOG.0000000000000862","article-title":"Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination","volume":"125","author":"Morgan","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"15","key":"10.1016\/j.vaccine.2017.01.042_b0140","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.2015.12790","article-title":"Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations","volume":"314","author":"Sukumaran","year":"2015","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.vaccine.2017.01.042_b0145","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/j.1471-0528.2012.03470.x","article-title":"Vaccination against H1N1 influenza with Pandemrix\u00ae during pregnancy and delivery outcome: a Swedish register study","volume":"119","author":"K\u00e4ll\u00e9n","year":"2012","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.vaccine.2017.01.042_b0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2012.6131","article-title":"Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy","volume":"308","author":"Pasternak","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2017.01.042_b0155","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jpeds.2014.01.037","article-title":"Vaccine safety datalink. Maternal influenza vaccine and risks for preterm or small for gestational age birth","volume":"164","author":"Nordin","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2017.01.042_b0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.earlhumdev.2016.04.010","article-title":"Obstetric and perinatal outcomes in women >40 years or age: associations with fetal growth disorders","volume":"100","author":"Zapata-Masias","year":"2016","journal-title":"Early Hum Dev"},{"issue":"11","key":"10.1016\/j.vaccine.2017.01.042_b0165","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3109\/14767058.2015.1060214","article-title":"Bariatric surgery and associated adverse pregnancy outcomes among obese women","volume":"29","author":"Parker","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"10.1016\/j.vaccine.2017.01.042_b0170","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1017\/S0950268808000915","article-title":"Impact of maternal malaria and under-nutrition on intrauterine growth restriction: a prospective ultrasound study in Democratic Republic of Congo","volume":"137","author":"Landis","year":"2009","journal-title":"Epidemiol Infect"},{"issue":"15","key":"10.1016\/j.vaccine.2017.01.042_b0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12884-015-0511-6","article-title":"Factors associated with ultrasound-aided detection of suboptimal fetal growth in a malaria-endemic area of Papua New Guinea","volume":"3","author":"Unger","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"10.1016\/j.vaccine.2017.01.042_b0180","doi-asserted-by":"crossref","first-page":"e53794","DOI":"10.1371\/journal.pone.0053794","article-title":"Malaria and fetal growth alterations in the 3(rd) trimester of pregnancy: a longitudinal ultrasound study","volume":"8","author":"Schmiegelow","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2017.01.042_b0185","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4269\/ajtmh.13-0285","article-title":"Effects of vivax malaria acquired before 20 weeks of pregnancy on subsequent changes in fetal growth","volume":"90","author":"Machado Filho","year":"2014","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2017.01.042_b0190","doi-asserted-by":"crossref","first-page":"e31411","DOI":"10.1371\/journal.pone.0031411","article-title":"Ultrasound evidence of early fetal growth restriction after maternal malaria infection","volume":"7","author":"Rijken","year":"2012","journal-title":"PLoS ONE"},{"issue":"35","key":"10.1016\/j.vaccine.2017.01.042_b0195","doi-asserted-by":"crossref","first-page":"e4777","DOI":"10.1097\/MD.0000000000004777","article-title":"Maternal HCV infection is associated with intrauterine fetal growth disturbance: a meta-analysis of observational studies","volume":"95","author":"Huang","year":"2016","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.01.042_b0200","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12884-016-0950-8","article-title":"Effect of maternal Helicobacter Pylori infection on birth weight in an urban community in Uganda","volume":"16","author":"Wanyama","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"10.1016\/j.vaccine.2017.01.042_b0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jogc.2015.10.013","article-title":"A ten-year review of antenatal complications and pregnancy outcomes among HIV-positive pregnant women","volume":"38","author":"Yudin","year":"2016","journal-title":"J Obstet Gynaecol Can"},{"issue":"6","key":"10.1016\/j.vaccine.2017.01.042_b0210","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00404-009-1186-x","article-title":"Obstetric and perinatal outcome in HIV positive women receiving HAART in urban Nigeria","volume":"281","author":"Olagbuji","year":"2010","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.vaccine.2017.01.042_b0215","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/QAI.0b013e3181958560","article-title":"Prevention Trial Group. Association of low CD4 cell count and intrauterine growth retardation in Thailand","volume":"50","author":"Cailhol","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.vaccine.2017.01.042_b0220","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1097\/01.AOG.0000466430.19823.53","article-title":"Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy","volume":"125","author":"American College of Obstetricians and Gynecologists","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"3 Suppl","key":"10.1016\/j.vaccine.2017.01.042_b0225","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ajog.2012.06.071","article-title":"A review of fetal and infant protection associated with antenatal influenza immunization","volume":"207","author":"Steinhoff","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"35","key":"10.1016\/j.vaccine.2017.01.042_b0230","first-page":"1193","article-title":"Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)\u2013United States, April 2009\u2013August 2010","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.01.042_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2016.07.032","article-title":"Guideline for collection, analysis, and presentation of safety data in clinical trials of vaccines in pregnant women","author":"Jones","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.042_b0240","doi-asserted-by":"crossref","unstructured":"Schlaudecker EP, Munoz FM, Bardaji A, Boghossian NS, Khalil A, Mousa H, et al. Small for gestational age: case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. Vaccine 2017;35(48):6710\u20136720.","DOI":"10.1016\/j.vaccine.2017.01.040"},{"key":"10.1016\/j.vaccine.2017.01.042_b0245","unstructured":"Clinical Practice Guideline Fetal Growth Restriction\u2014Definition, Diagnosis and Management. Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Clinical Strategy and Programmes, Health Service Executive; 2013. Available on the world wide web: https:\/\/www.hse.ie\/eng\/about\/Who\/clinical\/natclinprog\/obsandgynaeprogramme\/guidelines\/fetal.pdf [last accessed January 16, 2016]."},{"issue":"5","key":"10.1016\/j.vaccine.2017.01.042_b0250","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3109\/14767058.2010.516285","article-title":"Fundal height: a useful screening tool for fetal growth?","volume":"24","author":"Sparks","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.vaccine.2017.01.042_b0255","first-page":"CD008136","article-title":"Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth","volume":"9","author":"Robert Peter","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2017.01.042_b0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000359969","article-title":"Placental pathology in early-onset and late-onset fetal growth restriction","volume":"36","author":"Mifsud","year":"2014","journal-title":"Fetal Diagn Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2017.01.042_b0265","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/jp.2013.176","article-title":"Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes","volume":"34","author":"Odibo","year":"2014","journal-title":"J Perinatol"},{"issue":"6","key":"10.1016\/j.vaccine.2017.01.042_b0270","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.7863\/ultra.32.6.1083","article-title":"AIUM practice guideline for the performance of obstetric ultrasound examinations","volume":"32","author":"American Institute of Ultrasound in Medicine","year":"2013","journal-title":"J Ultrasound Med"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.01.042_b0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1471-0528.12313","article-title":"Ultrasound methodology used to construct the fetal growth standards in the INTERGROWTH 21st Project","volume":"120","author":"Papageorghiou","year":"2013","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.vaccine.2017.01.042_b0280","first-page":"CD008549","article-title":"Customised versus population-based growth charts as a screening tool for detecting small for gestational age infants in low-risk pregnant women","author":"Carberry","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.vaccine.2017.01.042_b0285","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S2213-8587(14)70121-4","article-title":"The likeness of fetal growth and newborn size across non-isolated populations in the INTERGRWOTH-21st Project: the fetal growth longitudinal study and newborn cross-sectional study","volume":"2","author":"Villar","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.01.042_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.10.931","article-title":"INTERGROWTH-21st vs customized birthweight standards for identification of perinatal mortality","volume":"214","author":"Anderson","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.01.042_b0295","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/1471-0528.12416","article-title":"Translating research into practice: the introduction of the INTERGROWTH-21st package of clinical standards, tools and guidelines into policies, programmes, and clinical services","volume":"120","author":"Chatfield","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.vaccine.2017.01.042_b0300","doi-asserted-by":"crossref","DOI":"10.1002\/uog.15884","article-title":"Consensus definition for placental fetal growth restriction: a Delphi procedure","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.01.042_b0305","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejogrb.2013.11.022","article-title":"Definition and management of fetal growth restriction: a survey of contemporary attitudes","volume":"174","author":"Unterscheider","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.vaccine.2017.01.042_b0310","unstructured":"Nicolaides K, Rizzo G, Hecher K, Ximenes R. Doppler in Obstetrics\u2014The Fetal Medicine Foundation. Accessed on the world wide web: https:\/\/fetalmedicine.org\/var\/uploads\/Doppler-in-Obstetrics.pdf [last accessed June 26, 2016]."},{"issue":"4","key":"10.1016\/j.vaccine.2017.01.042_b0315","article-title":"Defining the residual risk of adverse perinatal outcome in growth-restricted fetuses with normal umbilical artery blood flow","volume":"211","author":"O'Dwyer","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.01.042_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.10.024","article-title":"Is fetal cerebroplacental ration an independent predictor of intrapartum fetal compromise and neonatal unit admission?","volume":"213","author":"Khalil","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.01.042_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.10.013","article-title":"The association between fetal Doppler and admission to neonatal unit at term","volume":"213","author":"Khalil","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.01.042_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.05.008","article-title":"The role of brain sparing in the prediction of adverse outcomes in intrauterine growth restriction: results of the multicenter PORTO Study","volume":"211","author":"Flood","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.01.042_b0335","doi-asserted-by":"crossref","unstructured":"Quinn JA, Munoz FM, Gonick B, Frau L, Cutland C, Mallett-Moore T, et al. Preterm birth: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2016;34(49):6047\u201356.","DOI":"10.1016\/j.vaccine.2016.03.045"},{"key":"10.1016\/j.vaccine.2017.01.042_b0340","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guidelines for Clinical Safety assessment (E2a\u2013e). Available on the world wide web: http:\/\/www.ich.org\/ [last accessed: April 14, 2016]."},{"key":"10.1016\/j.vaccine.2017.01.042_b0345","unstructured":"Council for International Organizations of Medical Sciences (CIOMS). Reporting form for International Reporting of Adverse Drug Reactions. Available on the world wide web: http:\/\/www.cioms.ch\/frame what is cioms.htm [last accessed: April 14, 2016]."},{"issue":"15","key":"10.1016\/j.vaccine.2017.01.042_b0350","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"9193","key":"10.1016\/j.vaccine.2017.01.042_b0355","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.vaccine.2017.01.042_b0360","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T22:39:33Z","timestamp":1535236773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17301032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":72,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0264410X17301032"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fetal growth restriction: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}